| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | DEPOMED INC | 200,000 | 3,924,000 | 0.16% | ||
| 102 | VALEANT PHARMACEUTICALS INTL | 192,000 | 3,867,000 | 0.16% | ||
| 103 | ACCELERATE DIAGNOSTICS INC | 264,625 | 3,808,000 | 0.16% | ||
| 104 | ARIAD PHARMACEUTICALS ORD (NMS) | 502,000 | 3,710,000 | 0.15% | ||
| 105 | NEVRO CORP COM | 49,800 | 3,673,000 | 0.15% | ||
| 106 | COMMUNITY HEALTH SYS INC NEW | 304,472 | 3,669,000 | 0.15% | ||
| 107 | MEDIVATION INC | 60,000 | 3,618,000 | 0.15% | Call | |
| 108 | IMPAX LABORATORIES INC | 124,335 | 3,583,000 | 0.15% | ||
| 109 | AURIS MED HLDG AG | 834,263 | 3,496,000 | 0.14% | ||
| 110 | BEIGENE LTD | 116,707 | 3,478,000 | 0.14% | ||
| 111 | PERRIGO CO PLC | 37,300 | 3,382,000 | 0.14% | ||
| 112 | KARYOPHARM THERAPEUTICS INC COM | 500,324 | 3,357,000 | 0.14% | ||
| 113 | ASTRAZENECA PLC | 110,200 | 3,327,000 | 0.14% | Call | |
| 114 | AMERISOURCEBERGEN CORP | 41,500 | 3,292,000 | 0.13% | Call | |
| 115 | GLAXOSMITHKLINE PLC | 75,200 | 3,259,000 | 0.13% | Call | |
| 116 | CELGENE CORP | 31,200 | 3,077,000 | 0.13% | Call | |
| 117 | Wright Medical Group NV | 169,000 | 2,936,000 | 0.12% | Call | |
| 118 | MCKESSON CORP | 15,000 | 2,800,000 | 0.11% | ||
| 119 | GRIFOLS S A SP ADR REP B | 166,000 | 2,767,000 | 0.11% | ||
| 120 | IMMUNOMEDICS INC | 4,000,000 | 2,715,000 | 0.11% | PRN | |
| 121 | NOVAVAX INC COM | 358,000 | 2,603,000 | 0.11% | ||
| 122 | FORWARD PHARMA A/S | 136,547 | 2,481,000 | 0.10% | ||
| 123 | ADAPTIMMUNE THERAPEUTICS PLC | 296,934 | 2,420,000 | 0.10% | ||
| 124 | ARCA BIOPHARMA INCORPORATED COM PAR .001 | 811,227 | 2,353,000 | 0.10% | ||
| 125 | CARE CAP PPTYS INC | 84,316 | 2,210,000 | 0.09% | ||
| 126 | ALLSCRIPTS HEALTHCARE SOLUTN | 173,600 | 2,205,000 | 0.09% | ||
| 127 | DBV TECHNOLOGIES S A | 65,600 | 2,140,000 | 0.09% | ||
| 128 | BLUEBIRD BIO INC COM | 49,345 | 2,136,000 | 0.09% | ||
| 129 | Merus NV | 260,000 | 2,113,000 | 0.09% | ||
| 130 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 125,000 | 2,074,000 | 0.08% | ||
| 131 | KITE PHARMA INCORPORATED | 41,000 | 2,050,000 | 0.08% | ||
| 132 | INTELLIA THERAPEUTICS INC | 86,842 | 1,854,000 | 0.08% | ||
| 133 | ALLIQUA BIOMEDICAL INC | 1,650,000 | 1,848,000 | 0.08% | ||
| 134 | UNIQURE NV | 241,021 | 1,776,000 | 0.07% | ||
| 135 | HALOZYME THERAPEUTICS INC | 200,000 | 1,726,000 | 0.07% | ||
| 136 | MOMENTA PHARMACEUTICALS INC | 153,700 | 1,660,000 | 0.07% | ||
| 137 | FLEX PHARMA INC COM | 162,124 | 1,655,000 | 0.07% | ||
| 138 | MERRIMACK PHARMACEUTI | 1,485,000 | 1,654,000 | 0.07% | PRN | |
| 139 | SANOFI SPOND FUNSPONSORED ADR | 286,000 | 1,542,000 | 0.06% | ||
| 140 | AMGEN INC | 10,100 | 1,537,000 | 0.06% | Call | |
| 141 | AMICUS THERAPEUTICS INC COM | 258,000 | 1,409,000 | 0.06% | ||
| 142 | CIDARA THERAPEUTICS INC | 132,472 | 1,366,000 | 0.06% | ||
| 143 | INOTEK PHARMACEUTICALS CORP | 180,762 | 1,345,000 | 0.05% | ||
| 144 | CHIMERIX INC | 308,892 | 1,214,000 | 0.05% | ||
| 145 | REVANCE THERAPEUTICS INC COM | 75,000 | 1,020,000 | 0.04% | ||
| 146 | Esperion Therapeutics Inc | 102,800 | 1,016,000 | 0.04% | ||
| 147 | TETRAPHASE PHARMACEUTICALS INC COM | 192,322 | 827,000 | 0.03% | ||
| 148 | QUORUM HEALTH CORP | 76,118 | 815,000 | 0.03% | ||
| 149 | GENMARK DIAGNOSTICS INC. | 93,349 | 812,000 | 0.03% | ||
| 150 | BELLICUM PHARMACEUTICALS INCORPORATED | 60,000 | 778,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-16-139243, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
